The Board's Role in Cyber Security


A cyber-attack can swiftly put an organisation on its knees, causing huge amounts of damage both reputationally and financially. 

In this article, Criticaleye speaks to Bill Payne, a Board Mentor at Criticaleye and former Non-executive Chair of Atento and Reece Donovan, CEO of Iomart Group, about what Boards need to get right and some of the key questions to ask, such as: 

• When was the last penetration test?
• What did it reveal?
• What are the vulnerabilities in all our systems?
• What insurance cover do we have in place?

Share this with your Community


Contributors
Bill Payne
Board Mentor
Criticaleye
Reece Donovan
CEO / Director
Mayden


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

Technology Transformation is Not an IT Issue - It's a Leadership One

Successful transformation is not won by process alone. This article by Criticaleye Partner Hitachi Solutions explores the culture of partnership and the executive behaviours that turn plans into results. The piece ...


Click here to download this insight

BLOG | Unlocking Value as CPO

CPOs are navigating an era of rapid disruption: shaping workforce strategy, managing an evolving talent landscape, meeting rising expectations from the Board and acting as architects of organisational transformation....


Criticaleye Asia Podcast - Mastering Regional Leadership in Asia: Driving Change Across Markets

In this episode, Yu-Wen Hsiao, Marketing and Communications Manager, APAC at Criticaleye, speaks with Kalpesh R Parmar, General Manager, Mars Snacking Asia, about leading change and building high-performing teams acr...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 209




Aldermore Group Legal & General London Stock Exchange Group Canaccord Genuity Group Inc Drax Group plc NatWest Group British Land LACE Partners Rolls-Royce Hitachi Solutions Lightsource bp AlixPartners E.ON UK Worldpay Mayborn Group NATS GlaxoSmithKline plc